LYELL
Live / Registered — Registered (as of 21 Oct 2025)
What this means for you
Registered since 21 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90689664
- Registration number
- 7995051
- Mark type
- Stylized text
- Filed
- 04 May 2021
- Published for opposition
- 08 Mar 2022
- Registered
- 21 Oct 2025
- Attorney of record
- Christina L. Martini
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific research; biological research and development, namely, research and development utilizing integrated technology platforms combining chemical, molecular, genetic, protein and cell systems engineering technologies for therapeutic regulation of cells and cell systems, namely, therapeutic regulation of immune cells; biological research and development, namely, research and development related to treatment of cancer
Owner
- Lyell Immunopharma, Inc., South San Francisco, CA, US
- Lyell Immunopharma, Inc., South San Francisco, CA, US
- Lyell Immunopharma, Inc., South San Francisco, CA, US
Prosecution history
- 21 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 21 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Apr 2025 — USE AMENDMENT FILED
- 18 Sept 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Apr 2025 — TEAS STATEMENT OF USE RECEIVED
- 29 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2024 — SOU EXTENSION 5 GRANTED
- 29 Oct 2024 — SOU EXTENSION 5 FILED
- 29 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Apr 2024 — SOU EXTENSION 4 GRANTED
- 29 Apr 2024 — SOU EXTENSION 4 FILED